FourThought Financial Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
41,220
+1,170
+3% +$348K 1.05% 31
2025
Q4
$10.9M Buy
40,050
+687
+2% +$187K 0.92% 31
2025
Q3
$10.6M Buy
39,363
+140
+0.4% +$38.1K 0.94% 35
2025
Q2
$10.8M Sell
39,223
-431
-1% -$117K 1.07% 32
2025
Q1
$10.5M Sell
39,654
-642
-2% -$158K 1.1% 28
2024
Q4
$9.36M Buy
40,296
+622
+2% +$143K 0.97% 30
2024
Q3
$8.75M Buy
39,674
+16,390
+70% +$3.39M 1.04% 31
2024
Q2
$4.58M Buy
+23,284
New +$4.81M 0.59% 55

Other funds holding CME

FourThought Financial Partners's CME Position: Q1 2026 in Review

FourThought Financial Partners increased its CME Group (CME) stake by 2.9% in Q1 2026, buying an estimated $348K and bringing the position to 41,220 shares worth $12.2M. The position accounts for 1.05% of the portfolio, ranked #31.

FourThought Financial Partners first reported a position in CME in Q2 2024 and has held it in 8 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • FourThought Financial Partners held 41,220 shares of CME Group worth $12.2M as of Q1 2026.
  • FourThought Financial Partners bought 1,170 CME Group shares in Q1 2026, an estimated $348K.
  • CME Group made up 1.05% of FourThought Financial Partners's portfolio in Q1 2026, its #31 holding.
  • FourThought Financial Partners first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.